{"id":505641,"date":"2021-06-22T16:11:24","date_gmt":"2021-06-22T20:11:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\/"},"modified":"2021-06-22T16:11:24","modified_gmt":"2021-06-22T20:11:24","slug":"zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\/","title":{"rendered":"Zealand Pharma to Participate in LifeSci Nordic Biotech Summit"},"content":{"rendered":"<div class=\"mw_release\">\n<p>\n        <strong>C<\/strong><br \/>\n        <strong>ompany <\/strong><br \/>\n        <strong>a<\/strong><br \/>\n        <strong>nnouncement \u2013 No. <\/strong><br \/>\n        <strong>40<\/strong><br \/>\n        <strong>\/ 202<\/strong><br \/>\n        <strong>1<\/strong>\n      <\/p>\n<p>\n        <strong>Zealand Pharma <\/strong><br \/>\n        <strong>to Participate in <\/strong><br \/>\n        <strong>LifeSci<\/strong><br \/>\n        <strong> Nordic Biotech Summit<\/strong>\n      <\/p>\n<p>\n        <em>Copenhagen, D<\/em><br \/>\n        <em>K and Boston, MA<\/em><br \/>\n        <em>, <\/em><br \/>\n        <em>U.S. <\/em><br \/>\n        <em>June<\/em><br \/>\n        <em> 22<\/em><br \/>\n        <em>, 2021 \u2013<\/em> Zealand Pharma A\/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, today announced that members of its senior management team are scheduled to participate virtually in the LifeSci Nordic Biotech Summit.<\/p>\n<p>\n        <strong>LifeSci Nordic Biotech Summit<\/strong>\n      <\/p>\n<p>Date: Tuesday, June 29, 2021<br \/>Presentation: 1:30 p.m. ET \/ 7:30 p.m. CET<\/p>\n<p>A live webcast of the event will be available on the &#8220;Events &amp; Presentations&#8221; page in the Investor section of the Company&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RaapMogv11s0qqRBq7BWIign7kOrfh7h6LuRaz7HNED1J6MjZnf5TBm1T8CJUsRVM3fwdJ2lxnIRmnk3jktq_1_6HyurMYpkQMGPBkIF9kvq1i0vD_m6djGHnm7cq1nbIs-z5Vc2g4NnnldxUDV5NKCRky58Bvqqi7lUAdFsWQg=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.zealandpharma.com\/events-presentations<\/a>. A replay of the webcast will be archived on the Company&#8217;s website following the presentation.<\/p>\n<p align=\"center\">\n        <strong> # # #<\/strong>\n      <\/p>\n<p>\n        <strong>About Zealand Pharma A\/S <\/strong>\n      <\/p>\n<p>Zealand Pharma A\/S (Nasdaq: ZEAL) (&#8220;Zealand&#8221;) is a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market. Zealand\u2019s robust pipeline of investigational medicines includes three candidates in late stage development. Zealand markets V-Go\u00ae, abasal-bolus insulin delivery option for people with diabetes and has received approval for Zegalogue\u00ae (dasiglucagon), the first and only glucagon analogue for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 6 and above. License collaborations with Boehringer Ingelheim and Alexion Pharmaceuticals create opportunity for more patients to potentially benefit from Zealand-invented peptide therapeutics. Zealand was founded in 1998 in Copenhagen, Denmark, and has presence throughout the U.S. that includes key locations in New York, Boston, and Marlborough (MA). For more information about Zealand\u2019s business and activities, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=otDvLipePeR5oXBnlN7WckXUpUtiXXIMR0Tp5fsuQf9iiwKuMiYzwrBYfZtHen-Hm7grZp1AGnv-nGZYDk1ipDqxiUlIipzbghe2oy44GZY=\" rel=\"nofollow noopener\" target=\"_blank\">www.zealandpharma.com<\/a>.<\/p>\n<p>\n        <strong>For further information, please contact:<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;border-collapse:collapse\">\n<tr>\n<td>\n            <strong>Zealand Pharma Investor Relations<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td>Claudia Styslinger<\/td>\n<\/tr>\n<tr>\n<td>Argot Partners<\/td>\n<\/tr>\n<tr>\n<td>\n            <a href=\"mailto:investors@zealandpharma.com\" rel=\"nofollow noopener\" target=\"_blank\">investors@zealandpharma.com<\/a>\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>\u00a0<\/p>\n<table style=\"border-collapse: collapse;border-collapse:collapse\">\n<tr>\n<td>\n            <strong>Zealand Pharma<\/strong><br \/>\n            <strong>\u00a0Media Relations<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td>David Rosen<\/td>\n<\/tr>\n<tr>\n<td>Argot Partners\u00a0<\/td>\n<\/tr>\n<tr>\n<td>\n            <a href=\"mailto:media@zealandpharma.com\" rel=\"nofollow noopener\" target=\"_blank\">media@zealandpharma.com<\/a>\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>\n        \n      <\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUxMTg5OSM0MDA5NzAxODIjMjAwMTcwMQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml-eu.globenewswire.com\/release\/track\/00b59bca-b8b6-462b-afda-f37f6c3d701f\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>C ompany a nnouncement \u2013 No. 40 \/ 202 1 Zealand Pharma to Participate in LifeSci Nordic Biotech Summit Copenhagen, D K and Boston, MA , U.S. June 22 , 2021 \u2013 Zealand Pharma A\/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, today announced that members of its senior management team are scheduled to participate virtually in the LifeSci Nordic Biotech Summit. LifeSci Nordic Biotech Summit Date: Tuesday, June 29, 2021Presentation: 1:30 p.m. ET \/ 7:30 p.m. CET A live webcast of the event will be available on the &#8220;Events &amp; Presentations&#8221; page in the Investor section of the Company&#8217;s website at https:\/\/www.zealandpharma.com\/events-presentations. A replay of the webcast will &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Zealand Pharma to Participate in LifeSci Nordic Biotech Summit&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-505641","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Zealand Pharma to Participate in LifeSci Nordic Biotech Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zealand Pharma to Participate in LifeSci Nordic Biotech Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"C ompany a nnouncement \u2013 No. 40 \/ 202 1 Zealand Pharma to Participate in LifeSci Nordic Biotech Summit Copenhagen, D K and Boston, MA , U.S. June 22 , 2021 \u2013 Zealand Pharma A\/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, today announced that members of its senior management team are scheduled to participate virtually in the LifeSci Nordic Biotech Summit. LifeSci Nordic Biotech Summit Date: Tuesday, June 29, 2021Presentation: 1:30 p.m. ET \/ 7:30 p.m. CET A live webcast of the event will be available on the &#8220;Events &amp; Presentations&#8221; page in the Investor section of the Company&#8217;s website at https:\/\/www.zealandpharma.com\/events-presentations. A replay of the webcast will &hellip; Continue reading &quot;Zealand Pharma to Participate in LifeSci Nordic Biotech Summit&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-22T20:11:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUxMTg5OSM0MDA5NzAxODIjMjAwMTcwMQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Zealand Pharma to Participate in LifeSci Nordic Biotech Summit\",\"datePublished\":\"2021-06-22T20:11:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\\\/\"},\"wordCount\":317,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDUxMTg5OSM0MDA5NzAxODIjMjAwMTcwMQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\\\/\",\"name\":\"Zealand Pharma to Participate in LifeSci Nordic Biotech Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDUxMTg5OSM0MDA5NzAxODIjMjAwMTcwMQ==\",\"datePublished\":\"2021-06-22T20:11:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDUxMTg5OSM0MDA5NzAxODIjMjAwMTcwMQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDUxMTg5OSM0MDA5NzAxODIjMjAwMTcwMQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zealand Pharma to Participate in LifeSci Nordic Biotech Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zealand Pharma to Participate in LifeSci Nordic Biotech Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\/","og_locale":"en_US","og_type":"article","og_title":"Zealand Pharma to Participate in LifeSci Nordic Biotech Summit - Market Newsdesk","og_description":"C ompany a nnouncement \u2013 No. 40 \/ 202 1 Zealand Pharma to Participate in LifeSci Nordic Biotech Summit Copenhagen, D K and Boston, MA , U.S. June 22 , 2021 \u2013 Zealand Pharma A\/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, today announced that members of its senior management team are scheduled to participate virtually in the LifeSci Nordic Biotech Summit. LifeSci Nordic Biotech Summit Date: Tuesday, June 29, 2021Presentation: 1:30 p.m. ET \/ 7:30 p.m. CET A live webcast of the event will be available on the &#8220;Events &amp; Presentations&#8221; page in the Investor section of the Company&#8217;s website at https:\/\/www.zealandpharma.com\/events-presentations. A replay of the webcast will &hellip; Continue reading \"Zealand Pharma to Participate in LifeSci Nordic Biotech Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2021-06-22T20:11:24+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUxMTg5OSM0MDA5NzAxODIjMjAwMTcwMQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Zealand Pharma to Participate in LifeSci Nordic Biotech Summit","datePublished":"2021-06-22T20:11:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\/"},"wordCount":317,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUxMTg5OSM0MDA5NzAxODIjMjAwMTcwMQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\/","name":"Zealand Pharma to Participate in LifeSci Nordic Biotech Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUxMTg5OSM0MDA5NzAxODIjMjAwMTcwMQ==","datePublished":"2021-06-22T20:11:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUxMTg5OSM0MDA5NzAxODIjMjAwMTcwMQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUxMTg5OSM0MDA5NzAxODIjMjAwMTcwMQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-lifesci-nordic-biotech-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Zealand Pharma to Participate in LifeSci Nordic Biotech Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/505641","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=505641"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/505641\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=505641"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=505641"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=505641"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}